Learn More

This week's Fierce Biotech is brought to you by IQVIA.

Trouble viewing? Click here.

 
 
Discover how evidence-based assessments of your study design will proactively identify risks
 

Industry analysis reveals significant inefficiencies that can lead to unnecessary data collection and costly protocol amendments.

 

In this infographic we address the top 3 challenges of protocol design and the advantages of pressure testing your protocols with design analytics.

 
 
VIEW FULL INFOGRAPHIC
 

IQVIA’s Data-Informed Protocol Assessment helps you improve protocols by evaluating key areas of potential impact, such as patient burden and design inconsistencies. These analytics validate your design decisions and identify potential study risks prior to protocol finalization. Learn more.
 
 
 
Clinical Trial Analytics
 

IQVIA’s Clinical Trial Analytics Services can help you connect real-world data, machine learning and clinical expertise to reduce risk, improve timelines and accelerate enrollment.
 
LEARN MORE

Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact aalcover@questex.com or call 202-824-5074.



You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor  
New York, NY 10017